Hyperphagia: Clinical Trials

14 trials for Hyperphagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 114Completed 14
Phase 25Completed 5

Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)
Sodium Glycerophosphate Injection, Sodium Phosphates Injection - Parenteral Nutrition
Phase 1CompletedBaxter Healthcare Corporation422025-01-272025-06-29
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
Numeta G16%E, Sodium Glycerophosphate Injection - Parenteral Nutrition
Phase 1CompletedBaxter Healthcare Corporation162025-01-272025-06-29
LIPIDS-P Trial Phase I/II Trial
Smoflipid - Sepsis, Severe, Septic Shock
Phase 1 / Phase 2CompletedUniversity of Florida592018-08-172025-08-11
FDA Approved Medication to Reduce Binge Eating and/or Purging
Phentermine/Topiramate-First, Placebo - Binge Eating Disorder, Bulimia Nervosa
Phase 1CompletedStanford University222015-10-302018-05-14
Smartphone Technology and CBT-GSH in Binge Eaters
CBT-GSH, Noom Monitor - Binge Eating Disorder, Bulimia Nervosa
Phase 1CompletedIcahn School of Medicine at Mount Sinai662013-02-012016-05-03
Repetitive Transcranial Magnetic Stimulation of the DMPFC for Anorexia and Bulimia: an Open-Label Case Series
Repetitive Transcranial Magnetic Stimulation - Bulimia Nervosa, Anorexia Nervosa
Phase 1CompletedUniversity Health Network, Toronto602011-12-112020-06-01
Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training
Nutritional Counseling, Mindfulness Intervention - Stress, Obesity
Phase 1CompletedYale University1122010-09-012015-07-30
Binge Eating and Chromium Study
Sugar Pill, chromium picolinate - Binge Eating Disorder
Phase 1 / Phase 2CompletedUniversity of North Carolina, Chapel Hill262008-07-012012-04-03
Cholestasis Prevention: Efficacy of IV Fish Oil
Omegaven, Intralipid - Cholestasis, Parenteral Nutrition
Phase 1CompletedBoston Children's Hospital192007-07-012020-12-03
Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain
Interpersonal Psychotherapy - Overweight Adolescents, Overweight
Phase 1CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1472005-12-052017-10-06
Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
Cognitive Behavioral Therapy - Bulimia Nervosa
Phase 1 / Phase 2CompletedKaiser Permanente262005-09-012010-02-15
Internet Weight Control for Bingeing Adolescents
Internet-based intervention designed to reduce binge eating and improve healthy weight regulation - Obesity, Eating Disorders
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1202005-02-012010-01-18
The Psychological Treatment of Overweight Binge Eaters Minority Supplement
Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT) - Binge Eating Disorder, Cognitive Therapy/Methods
Phase 1 / Phase 2CompletedWashington University School of Medicine1621997-04-012010-09-28
Psychological Treatment of Overweight Binge Eaters
Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT) - Binge Eating Disorder, Cognitive Therapy/Methods
Phase 1 / Phase 2CompletedWashington University School of Medicine1621994-04-012010-09-23

Narrower conditions

Bulimia (9)  ·  Binge-Eating Disorder (5)  ·  Obesity (5)  ·  Bulimia Nervosa (4)  ·  Feeding and Eating Disorders (4)  ·  Mental Disorders (2)  ·  Anorexia (1)  ·  Anorexia Nervosa (1)  ·  Cholestasis (1)  ·  Overweight (1)  ·  Sepsis (1)  ·  Shock, Septic (1)  ·  Short Bowel Syndrome (1)  ·  Social Adjustment (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (14)  ·  Signs and Symptoms (14)  ·  Signs and Symptoms, Digestive (14)  ·  Mental Disorders (7)  ·  Body Weight (5)  ·  Feeding and Eating Disorders (5)  ·  Nutrition Disorders (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Overnutrition (5)  ·  Overweight (4)  ·  Pathologic Processes (2)  ·  Behavior (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)

Interventions

Cognitive Behavioral Therapy (3)  ·  alpha-glycerophosphoric acid (2)  ·  Interpersonal Psychotherapy (1)  ·  Nutrition Assessment (1)  ·  Parenteral Nutrition, Total (1)  ·  Phentermine (1)  ·  Qsymia (1)  ·  SMOFlipid (1)  ·  Sugars (1)  ·  Transcranial Magnetic Stimulation (1)  ·  fish oil triglycerides (1)  ·  picolinic acid (1)  ·  soybean oil, phospholipid emulsion (1)

Sponsors

Baxter Healthcare Corporation (2)  ·  Washington University School of Medicine (2)  ·  Boston Children's Hospital (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kaiser Permanente (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Stanford University (1)  ·  University Health Network, Toronto (1)  ·  University of Florida (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Yale University (1)

Countries

United States (12)

Top investigators

Denise E Wilfley, Ph.D. (2)  ·  Erika Ryan, DCN, MS, RD, CDN, CNSC (2)  ·  Blake Woodside, MD (1)  ·  C. Barr Taylor, M.D. (1)  ·  Debra L Safer, MD (1)  ·  Faheem W Guirgis, MD (1)  ·  Jack A Yanovski, M.D. (1)  ·  Jonathan Downar, MD (1)  ·  Kimberly A Brownley, PhD (1)  ·  Lynn L DeBar, PhD MPH (1)  ·  Mark Puder, MD, PhD (1)  ·  Rajita Sinha, PhD (1)  ·  Sarah Adler, PsyD (1)  ·  Shebani Sethi, MD (1)  ·  Tom Hildebrandt, PsyD (1)

Results publications

PMID 12150647, PMID 18310192, PMID 22282429, PMID 23751236, PMID 23770843, PMID 26210388, PMID 28714097, PMID 28960384, PMID 29038069, PMID 31537565, PMID 31721257, PMID 33392541, PMID 33865456, PMID 38271099, PMID 38488429, PMID 39716214

NIH funding

R41MH096435 (1)